Bio Campus II
Now operational with Plant 5, Bio Campus II is projected to be fully completed by 2032. The centralized campus will enable clients to close the gap between demand and supply of life-saving biologics.
Plant 5
180 kL

Plant 5 is located in Bio Campus 2 and is scheduled for completion in April 2025, with a production capacity of 180,000 liters.

Plant 6
180 kL

Plant 6 is located in Bio Campus 2 and is scheduled for completion in 2032, with a production capacity of 180,000 liters.

Plant 7
180 kL

Plant 7 is located in Bio Campus 2 and is scheduled for completion in 2032, with a production capacity of 180,000 liters.

Plant 8
180 kL

Open
Innovation

The Samsung Biologics Open Innovation Center is located in Bio Campus 2 and is scheduled for completion in 2032.

Bio Campus II
  • Total Capacity
    by 2032

  • 720 kL

  • Continuous improvement with simplification
    and standardization, leveraging experience
    and expertise from Bio Campus I

  • Bio Campus 2, consisting of Plant 5, Plant 6, Plant 7, and Plant 8, has a total production capacity of 720 kL.
    Plant 5 is the DREAM PLANT — built for your success and always within your reach.
    Plant 5 embodies speed to market, integrated design, full automation, and carbon neutrality.
    Operational in April 2025.
    Driven. For Life. Samsungbiologics.
  • Real-time Data Sharing

    • • MBR, Pl online, SAP, Quality, LIMS data
    • • Centralized data sharing through Samsung Biologics Client Portal (SCP)
  • Digitalized Process Control Strategy

    • • Electronic Lab Notebook (ELN) and eMBR
    • • Digital-based employee training
  • Integration & Automation

    • • Operational excellence through integrated plants and laboratories
    • • Autonomous Mobile Robot (AMR), Manufacturing Execution System (MES)

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION